Gordon Nye Presents ClearIT at LSI USA '23

ClearIT is an emerging medtech company developing a new, painless, single treatment for tattoo removal.
Speakers
Gordon Nye
Gordon Nye
CEO, ClearIT

Transcription

Gordon Nye  0:05  

Good morning. I'm Gordon, I am the CEO of Novacap Solutions, also known as Clear Intradermal Technologies. We are embarking on solving great unmet need, which is safe, effective, painless tattoo removal for unwanted or regretted tattoos? How many people here know someone with a tattoo? And then how many? Do you know who regret that tattoo? Okay, so it's actually one in five. Globally, this is researched over and again, they can't nail down a different number than 20% of tattoos or regretted. Now what do you do about that regret is another thing. Long sleeves are start. But oftentimes, you've got Barbara on your bicep and you're dating Karen, and it's a problem, you got to get it to go away. Just a little sidebar, we're rebranding ourselves. Because in the journey of solving tattoo removal, we've discovered that our platform will have efficacious outcomes for surface treatments of the skin. So we're broader than just tattoo removal now. So the corporate brand will become Novacap Solutions, and in fact, will be listed hopefully, upcoming in May on the Neo Exchange in Canada, which is our fundraising initiative. What cap is called atmospheric plasma is beyond me, I'm an English major. However, it is used in industrial sterilization all the way through healthcare and medicine in wound care. And what cold atmospheric plasma does depends on where you direct it. In the case of gleam our surface treatment, it hits the surface of the skin and effects a lot of great aesthetic outcomes, including reduction of inflammation, controlling acne, psoriasis, and other skin disorders. underneath the surface of the skin very shallowly, I should say, we deliver it to the macrophage cells that hold tattoo ink, the cold atmospheric plasma, obliterates those macrophages loosening the tattoo, ink particles, and then our device removes those ink particles safely. Our primary market is tattoo removal. And you'll see why in a second, it's huge, also is going to take quite a heavy lift from a regulatory standpoint, it's probably a Dinoco 510 K. So along the way, we anticipate that our surface application will get a relatively quick clearance and will be revenue generating by the end of this calendar year. The system, the platform will be shared by both the surface and the tattoo removal device. But the platform the generator of the cap will be shared. Well focus primarily on the tattoo market this this talk. It's an unsolved problem for most people. And I'll explain why in a sec. The art and the other thing is we go to our website, you'll see that we we encourage tattoos, because the one in five doesn't change. So if tattoos are growing, so is our addressable market by definition. But we don't discourage or criticize the art of tattooing. It's a very popular form of self expression. The younger you are, the more likely you are to get one. Both genders have an equal number. Once you're under the age of 41, and five have regret. And only one in 15 do anything about it because the current solutions are so awful. Who gets them removed? This is another interesting fact. Even though men and women have the same number of regretted tattoos, women get them removed twice as much more than twice as much as men. And that's because men can't take care of procedural pain as well as women. That's my hypothesis. I think it's true too. And the other thing you'll see there's a great website for those of us in aesthetics called Real self.com Where constituents rate various proceed features in terms of their affordability, popularity, efficacy, and so forth. The patient satisfaction for tattoo removal, as it's done today is 18%. That totally breaks the business model of our practices, our practices rely on cross selling, you come in for Botox Next time, let's do some laser hair removal, etc, etc, and they cross sell happy patients. If you have an unhappy patient who's not satisfied, that breaks the model. Getting a tattoo is pretty straightforward. The ink gets injected just below below the surface of the skin. laser removal comes back to that same spot directs energy at the macrophages that hold the ink and ablates each of those cells painfully so a laser can only see one color at a time. And that explains why there are multiple multiple treatments required. If you are targeted to blue, you will skip right by red. So that requires another treatment 90 days later. And usually they're not completely effective. So it's doubled treatments by color. Over time, the average lead laser removal procedure lasts about a year and a half, or takes about a year and a half, six to nine appointments and each one excruciating. This kid on the left that you're seeing this is his back six weeks after treatment number 10. And that's not a typical in the Nova cap solution realm. We don't involve ablation of anything. We have one to two treatments projected. I mentioned to only if the clinician misses a spot, one treatment, no downtime, no injury. It's affordable because it's one treatment and practices only need to recover the chair time amounting to about 50 minutes. And it's safe and effective. Doctors therefore will love it because their patients are happy. In addition, it's it will be a profitable procedure. It treats all in colors, and it also treats all skin types. The way we work as I described a little earlier, we deliver in step one, our cold atmospheric plasma to the target, the target is killed, the macrophage is killed, the ink is loosened, and then we reverse energy and suck the ink out through the hollow needle that the cap came in through. We're partnering with world class organizations from manufacturing to r&d to clinical research, distribution legal. It's a who's who our next steps right now with Patel are finishing our design, freezing it and then doing verification testing clinical research and ultimately submission to FDA over the arc of the next year to year and a half depending on which device we're talking about. We have seven issued patents globally. Got 2021 pending right now. The fortress that we built around the claret method is substantial. Our target market just to be clear is not tattoo parlors, we're looking at board certified derms and plastics. Huge market gonna double maybe more in the next couple of years. Thanks to us, and a very seasoned leadership team. Thank you very much

 

 

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow